Hepatitis B prevention in Victoria, Australia - the potential to protect

Eurosurveillance

Volumn 16, Issue 22, 2011, Pages

  Williams, S ^a,b,c   Vally, H ^b,d   Fielding, J ^a,c   Cowie, B ^c,e  

^a Department of Health ^*  (Australia)

^b The Australian National University   (Australia)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^d LA TROBE UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE MANAGEMENT; HEALTH SERVICE; HEALTH SURVEY; HEPATITIS B; HIGH RISK PATIENT; HUMAN; IMMIGRANT; INFECTION PREVENTION; INFECTION RISK; MALE; PHYSICIAN ATTITUDE; SCHOOL CHILD; SCREENING TEST; VACCINATION;

EID: 79959454593     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.16.22.19879-en     Document Type: Article

References (36)

1. World Health Organization (WHO). Hepatitis B. Fact Sheet No.204. Geneva: WHO; August 2008. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/index.html
2. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol. 2005;34(6):1329-1339.
3. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97-107.
4. Wood N, Backhouse J, Gidding HF, Gilbert GL, Lum G, McIntyre PB. Estimates of chronic hepatitis B virus infection in the Northern Territory. Commun Dis Intell. 2005;29(3):289-290.
5. The Australian Immunisation Handbook. 9th ed. Canberra, Australia: Australian Government Department of Health and Ageing; 2008, updated 2009. Available from: http://www.health.gov.au/internet/immunise/publishing.nsf/Content/Handbook-home.
6. Clements CJ, Baoping Y, Crouch A, Hipgrave D, Mansoor O, Nelson CB, et al. Progress in the control of hepatitis B infection in the Western Pacific Region. Vaccine. 2006;24(12):1975-1982.
7. O'Sullivan B, Gidding HF, Law M, Kaldor JM, Gilbert GL, Dore GJ, et al. Estimates of chronic hepatitis B virus infection in Australia, 2000. Aust N Z J Public Health. 2004;28(3):212-216.
8. Nguyen VT, Razali K, Amin J, Law MG, Dore GJ. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries. J Gastroenterol Hepatol. 2008;23(6):922-929.
9. Gidding HF, Warlow M, MacIntyre CR, Backhouse J, Gilbert GL, Quinn HE, et al. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia. Vaccine. 2007;25(51):8637-8641.
10. Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet. 2006;368(9539):938-945.
11. Cowie B, Kelly, H. Outcomes of a complex dynamic mathematical model of hepatitis B virus in Australia (PP-027). Proceedings of the 20th Conference of the Asian Pacific Association for the Study of the Liver (APASL); 2010 Mar 26-28; Beijing, China. Hepatol Int. 2010;4(1):101.
12. Australian national notifiable diseases and case definitions. Hepatitis B (unspecified) case definition. Canberra, Australia: Australian Government Department of Health and Ageing; Mar 2004. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_hepbun.htm
13. Williams S, Vally H, Fielding J, Cowie B. Chronic hepatitis B surveillance in Victoria, 1998-2008: instituting a 21st century approach to an old disease. Aust N Z J Public Health. 2011;35(1):16-21.
14. Cowie B, Karapanagiotidis T, Enriquez A, Kelly, H. Markers of hepatitis B virus infection and immunity in Victoria, Australia, 1995 to 2005. Aust N Z J Public Health. 2010;34(1):72-78
15. Yuen MF. Revisiting the natural history of chronic hepatitis B: impact of new concepts on clinical management. J Gastroenterol Hepatol. 2007;22(7):973-976.
16. Robotin MC, George J, Supramaniam R, Sitas F, Penman AG. Preventing primary liver cancer: how well are we faring towards a national hepatitis B strategy? Med J Aust. 2008;188(6):363-365.
17. Coates M, Tracey E. Cancer in New South Wales: Incidence and mortality 1997. N S W Public Health Bull. 2001;12(2):40-42.
18. Immunisation Section. Criteria for government funded vaccine. Fact Sheet. Victoria, Australia: Victorian Government Department of Health; Nov 2010. Available from: http://www.health.vic.gov.au/__data/assets/pdf_file/0018/414171/Criteria-government-vaccine-Nov.10.pdf.
19. Hutton DW, Tan D, So SK, Brandeau ML. Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Ann Intern Med. 2007;147(7):460-469.
20. Weinberg MS, Gunn RA, Mast EE, Gresham L, Ginsberg M. Preventing transmission of hepatitis B virus from people with chronic infection. Am J Prev Med. 2001;20(4):272-276.
21. Weinbaum C, Williams I, Mast E, Wang S, Finelli L, Wasley A, et al. Recommendations for Identification and Public Health Management of persons with chronic hepatitis B. MMWR Recomm Rep. 2008;57(RR-8):1-20.
22. Rantala M, van de Laar MJ. Surveillance and epidemiology of hepatitis B and C in Europe - a review. Euro Surveill. 2008;13(21). pii:18880. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18880
23. Caruana SR, Kelly HA, De Silva SL, Chea L, Nuon S, Saykao P, et al. Knowledge about hepatitis and previous exposure to hepatitis viruses in immigrants and refugees from the Mekong Region. Aust N Z J Public Health. 2005;29(1):64-68.
24. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54(RR-16):1-31.
25. Richardson G, Evans M, Westmoreland D. Hepatitis B immunisation of household contacts: retrospective study of vaccine coverage. J Epidemiol Community Health. 2001;55(12):934-935.
26. Stroffolini T, Mele A, Tosti M, Gallo G, Balocchini E, Ragni P, et al. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol. 2000;33(6):980-985.
27. Tawk HM, Vickery K, Bisset L, Selby W, Cossart YE. The impact of hepatitis B vaccination in a Western country: recall of vaccination and serological status in Australian adults. Vaccine. 2006;24(8):1095-106.
28. Kretzschmar M, Mangen MJ, van de Laar M, de Wit A. Model based analysis of hepatitis B vaccination strategies in the Netherlands. Vaccine. 2009;27(8):1254-1260.
29. van Houdt R, Koedijk FD, Bruisten SM, Coul EL, Heijnen ML, Waldhober Q, et al. Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work? Vaccine. 2009;27(27):3530-3535.
30. Williams SJ, Craig PI, Liddle C, Batey RG, Farrell GC. Hepatitis B in Australia: determinants of intrafamily spread. Aust N Z J Med. 1987;17(2):220-227.
31. van Steenbergen JE, Baayen D, Peerbooms PG, Coutinho RA, van den Hoek A. Much gained by integrating contact tracing and vaccination in the hepatitis B antenatal screening program in Amsterdam, 1992-1999. J Hepatol. 2004;40(6):979-985.
32. World Health Organization (WHO). Ottawa Charter for Health Promotion. First International Conference on Health Promotion: The move towards a new public health, Ottawa, Ontario, Canada. 17-21 Nov 1986. Geneva:WHO. Available from: http://www.who.int/hpr/NPH/docs/ottawa_charter_hp.pdf
33. Hahné S, Wörmann Nee Marschall T, Kretzschmar M. Migrants and hepatitis B: new strategies for secondary prevention needed. Eur J Public Health. 2009;19(4):439.
34. Giraudon I, Permalloo N, Nixon G, Charlett A, Cohuet S, Mandal S, et al. Factors associated with incomplete vaccination of babies at risk of perinatal hepatitis B transmission: a London study in 2006. Vaccine. 2009;27(14):2016-2022.
35. Veldhuijzen I, Toy M, Hahné S, De Wit G, Schalm S, de Man RA, et al. Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology. 2010;138(2):522-530.
36. Mereckiene J, Cotter S, Lopalco P, D'Ancona F, Levy-Bruhl D, Giambi C, et al. Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009? Vaccine. 2010;28(28):4470-4477.